smartphon build updat first quarter cut deepest
latest smartphon build forecast reflect initi impact
viru iphon build expect unit y/i
previous huawei oppo xiaomi build also though due
inventori manag demand weak samsung except build
unchang given relianc non-china base manufactur
link full note
conjunct broader team smartphon monthli report
lower estim sever handset expos name reflect lower
iphon build addit china domest build weak due
coronaviru outbreak estim unchang given fluid
situat limit visibl asia check on-going frequent
link full note
pleas see addendum report import disclosur
updat revenu guidanc impact coronaviru
expect net revenu growth pt prior guidanc
net revenu growth low end low-teen guidanc rang
assum impact lower estim assum
impact persist expect payment compani affect
link full note
lower estim price target simo
reflect best view current product plan across smartphon suppli chain
spread result low factori util modest demand
destruct near-term impact beli robust multi-year content
stori memori rffe circuit protect flagship
link full note
initi coverag target rate address signific
unmet need medic dermatolog derisk lead asset target reflect
opportun inhibitor psoriasi alreadi
demonstr solid phase ii efficaci toler success ad
well earlier stage asset could meaning add
link full note
improv eas liquid concern smart attach rate
improv cash posit exit cash q/
 increas includ close verisur partnership compon
shortag relat coronaviru expect impact
impact shortag like delay product introduct see
attach rate smart next catalyst share
link full note
closer review propos bt sale alstom suggest make strateg financi
sens surmount regulatori risk aviat divestitur sustain liquid
deal set close specul given net debt/ebitda
stock sell-off sinc deal announc offer attract risk-reward pt
yld exclud bt sale
link full note
quick take posit print plenti digest
first strong oil street cfp street beat lower capital-expenditure
 street continu effici gain guid screen effici
oil street critic capital-expenditure perhap key take print
management chang ceo chairman mark papa retir water sale
proce up-front plug outspend
link full note
quarterli companion growth balanc focu
share u/p xop ytd aspir challeng
current strip consensu oil expect maintain
bakken/ scoop stack rig grow expect updat long-
lead project long bakken next phase springboard
ration activ neutral profil
link full note
acquir peopl clean beauti brand all-cash transact
sale first-ev acquisit expect yield
synergi form product cost distribut effici given exist
retail partner overlap expect acquisit yield increment
revenu lsd ep
link full note
takeaway metro connect fiber interest remain high privat market
recent attend metro connect miami fl met w/ infra
operators/investor takeaway report includ reemerg focu resi
assets/ftth privat investor privat valu fiber co valuat remain
robust true promis next growth opp although time still tbd
takeaway bode well plan sell fiber asset year
link full note
gh beat expect balanc volume/revenu upsid via clinic test
pharmaceut partner guidanc set ahead exist consensu
expect continu view gh one favorit high-growth stock
coverag reiter rate price target
link full note
earn glanc
modest neg earn appear bit light may includ one-tim
benefit brazil ebitda guidanc consensu right line
expect strong affirm began maiden contract januari
avoid delay robot outlook appear robust two addit
vessel oper north sea
link full note
new confirm case continu outsid china monday sunday level
new case itali korea iran remain less clear china new case
stabl almost entir hubei death new suspect case
better sunday low bar report airlin hotel ota refin
link full note
strong revenu growth off-set lower margin due product/custom
mix one-tim custom adjust guid came slightli
expect growth stori acceler deploy remain
track see potenti addit restructur believ momentum
network solut outcom drive margin improv
link full note
earn glanc
posit strong earn beat guidanc less line consensu
chang ebitda outlook subsea product book strong order
compani gener capital-expenditure slighli higher due time
link full note
product declin intensifi forc guid pt unchang
report weaker expect result declin product revenue
y/i vs y/i caus overal rev come our/con est
given declin product revenue expect declin management lower
rev/ep guid lower lt est remain
target reiter market perform pt
link full note
posit pre-releas ebitda beat con
consolid ebitda/fleet grew q/q drive beat activ
line guidanc use midpoint activ guid assum flat
profit impli upsid con audit committe complet fact find
associ intern review still financi restat requir
link full note
new data suggest develop extend sd microarray track success
late monday qtnt report new concord data extend sd microarray
favor result hbv hcv bode well success
develop extend sd microarray latest releas also keep qtnt
track hit develop mileston mosaiq platform time reiter
link full note
revanc enter commerci stage believ
differenti asset via daxi recent acquir dermal filler importantli
introduct dermal filler provid initi infrastructur
ahead anticip late fall approv daxi continu believ new
manag strongli differenti stori
link full note
requir convinc juic worth squeez
miss comp guid comp consensu
backdrop soft sale seem continu qtd believ
provid increment confid long term benefit transit onto
exclus partner worth near term headach await clearer updat
compani see green shoot transit
link full note
last week featur interest develop rpa market leader includ
uipath financi disclosur -- exit million -- ceo
